22-32475031-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_012179.4(FBXO7):c.29G>A(p.Arg10Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000123 in 1,541,508 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012179.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXO7 | NM_012179.4 | c.29G>A | p.Arg10Gln | missense_variant | 1/9 | ENST00000266087.12 | NP_036311.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO7 | ENST00000266087.12 | c.29G>A | p.Arg10Gln | missense_variant | 1/9 | 1 | NM_012179.4 | ENSP00000266087.7 | ||
FBXO7 | ENST00000420700.5 | n.29G>A | non_coding_transcript_exon_variant | 1/8 | 5 | ENSP00000406155.1 | ||||
FBXO7 | ENST00000425028.5 | n.29G>A | non_coding_transcript_exon_variant | 1/9 | 5 | ENSP00000395823.1 | ||||
FBXO7 | ENST00000492535.1 | n.17G>A | non_coding_transcript_exon_variant | 1/7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152236Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000147 AC: 2AN: 136330Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 74050
GnomAD4 exome AF: 0.00000864 AC: 12AN: 1389160Hom.: 0 Cov.: 31 AF XY: 0.00000292 AC XY: 2AN XY: 685402
GnomAD4 genome AF: 0.0000459 AC: 7AN: 152348Hom.: 0 Cov.: 33 AF XY: 0.0000268 AC XY: 2AN XY: 74502
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | The c.29G>A (p.R10Q) alteration is located in exon 1 (coding exon 1) of the FBXO7 gene. This alteration results from a G to A substitution at nucleotide position 29, causing the arginine (R) at amino acid position 10 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at